Hot Products

Chrysosplenetin
Catalog No: CFN97026

Chrysosplenetin is a metabolic inhibitor of artemisinin, it has strong activity in vitro against EV71 with low cytotoxicity. Co-administration of artemisinin(ART) with chrysosplenetin(CHR) in ratio of 1:2 achieved a synergic anti-malarial effect partly because of the noncompetitive or uncompetitive inhibition of CHR of drug-metabolism enzymes, especially CYP3A which is closely related to the auto-induction of ART.

Chrysosplenol D
Catalog No: CFN99622

Chrysosplenol D, an efflux pump inhibitor that can potentiate the activity of commercially important antibiotics and antimalarials. Chrysosplenol D has anti-inflammatory, antimalarial, antibacterial and antifungal activities; it also exerts its anti-proliferative effect on tsFT210 cells through inhibiting cell cycle and inducing apoptosis, it may as a new cell cycle inhibitor.

Cichoriin
Catalog No: CFN95196

Cichoriin is a photosensitive compound, it could be used as herbal photosensitizing agent in treating benign breast tumor in rats.

Cimicidanol 3-O-alpha-L-arabinoside
Catalog No: CFN90863

Reference standards.

Cimicifugic acid B
Catalog No: CFN70303

Cimicifugic acid B shows inhibitory collagenolytic activity.

Cimicifugic acid F
Catalog No: CFN70314

Cimicifugic acid F has antioxidant activity. Cimicifugic acid F shows inhibition of neutrophil elastase activity with an IC50 of 18 mumol/L. It also shows strong hyaluronidase inhibitory activity.

Cimicifugoside H1
Catalog No: CFN92973

Cimicifugoside H1 shows the protective function to cerebral neuron during cerebral ischemia.

Cimicifugoside H2
Catalog No: CFN92972

Cimicifugoside H2 is a natural product from Cimicifuga foetida.

Cimidahurinine
Catalog No: CFN99465

Cimidahurinine can attenuate Doxorubicin (DOX)-induced cardiotoxicity in a dose-dependent manner with EC50 values of 45.79 uM; it protects against cardiotoxicity by decreasing reactive oxygen species (ROS) accumulation and downregulating apoptosis-related Bax/Bcl-2 proteins.

Cimifugin
Catalog No: CFN98612

Cimifugin evidently inhibits FITC-induced type 2 allergic contact dermatitis,and its mechanism might related to regulating the balance of Th1 /Th2 by inhibiting type 2 cytokines. Cimifugin displayed low to moderate inhibition towards AChE and BChE (3.12 and 21.63%, respectively) at 200 ug/mL.